Details of the Drug Therapeutic Target (DTT)

General Information of Drug Therapeutic Target (DTT) (ID: TT5TOX7)

DTT Name Human immunodeficiency virus Maturation (HIV Mat)
Gene Name HIV Mat
DTT Type
Clinical trial target
 [1]
UniProt ID
NOUNIPROTAC
TTD ID
T99907

Molecular Interaction Atlas (MIA) of This DTT

Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This DTT
3 Clinical Trial Drug(s) Targeting This DTT
Drug Name Drug ID Indication ICD 11 Highest Status REF
BMS-955176 DMMEAGO Human immunodeficiency virus-1 infection 1C62 Phase 2 [2]
GSK2838232 DMCIGRW Human immunodeficiency virus-1 infection 1C62 Phase 2 [1]
GSK3640254 DMMOWT9 Human immunodeficiency virus infection 1C62 Phase 2 [3]
------------------------------------------------------------------------------------

References

1 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800037762)
2 Clinical pipeline report, company report or official report of Bristol-Myers Squibb.
3 Phase I evaluation of the safety, tolerability, and pharmacokinetics of GSK3640254, a next-generation HIV-1 maturation inhibitor. Pharmacol Res Perspect. 2020 Dec;8(6):e00671.